Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivayla Apostolova

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Brain FDG PET for the Etiological Diagnosis of Clinically Uncertain Cognitive Impairment During Delirium in RemissionFranziska Mathies, Catharina Lange, Anja Mäurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Test-Retest Variability in Lesion SUV and Lesion SUR in <sup>18</sup>F-FDG PET: An Analysis of Data from Two Prospective Multicenter TrialsFrank Hofheinz, Ivayla Apostolova, Liane Oehme, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2023
Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptanceThomas Budenkotte, Ivayla Apostolova, Roland Opfer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2024
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropionIvayla Apostolova, Sabine Hellwig, Amir Karimzadeh, et al.
Clinical Nuclear Medicine|December 27, 2019
Nigrostriatal Degeneration in the Cognitive Part of the Striatum in Parkinson Disease Is Associated With Frontomedial HypometabolismIvayla Apostolova, Catharina Lange, Lars Frings, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2023
No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndromeTassilo Schiebler, Ivayla Apostolova, Franziska Lara Mathies, et al.
Annals of Nuclear Medicine|October 19, 2011
Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?Peter Bannas, Thorsten Derlin, Michael Groth, et al.
EJNMMI Physics|July 17, 2024
Organ and tumor dosimetry including method simplification for [<sup>177</sup>Lu]Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancerAmir Karimzadeh, Linus Schatz, Markus Sauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromesMahmood Nazari, Andreas Kluge, Ivayla Apostolova, et al.
Annals of Nuclear Medicine|May 8, 2010
SPECT/CT stabilizes the interpretation of somatostatin receptor scintigraphy findings: a retrospective analysis of inter-rater agreementIvayla Apostolova, Swantje Riethdorf, Ralph Buchert, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Brain FDG PET for the Etiological Diagnosis of Clinically Uncertain Cognitive Impairment During Delirium in RemissionFranziska Mathies, Catharina Lange, Anja Mäurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Test-Retest Variability in Lesion SUV and Lesion SUR in <sup>18</sup>F-FDG PET: An Analysis of Data from Two Prospective Multicenter TrialsFrank Hofheinz, Ivayla Apostolova, Liane Oehme, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2023
Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptanceThomas Budenkotte, Ivayla Apostolova, Roland Opfer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2024
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropionIvayla Apostolova, Sabine Hellwig, Amir Karimzadeh, et al.
Clinical Nuclear Medicine|December 27, 2019
Nigrostriatal Degeneration in the Cognitive Part of the Striatum in Parkinson Disease Is Associated With Frontomedial HypometabolismIvayla Apostolova, Catharina Lange, Lars Frings, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2023
No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndromeTassilo Schiebler, Ivayla Apostolova, Franziska Lara Mathies, et al.
Annals of Nuclear Medicine|October 19, 2011
Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?Peter Bannas, Thorsten Derlin, Michael Groth, et al.
EJNMMI Physics|July 17, 2024
Organ and tumor dosimetry including method simplification for [<sup>177</sup>Lu]Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancerAmir Karimzadeh, Linus Schatz, Markus Sauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromesMahmood Nazari, Andreas Kluge, Ivayla Apostolova, et al.
Annals of Nuclear Medicine|May 8, 2010
SPECT/CT stabilizes the interpretation of somatostatin receptor scintigraphy findings: a retrospective analysis of inter-rater agreementIvayla Apostolova, Swantje Riethdorf, Ralph Buchert, et al.
Pageof 10